Current status and legal/ethical problems in the research use of the tissues of aborted human fetuses in Japan
- 23 June 2020
- journal article
- research article
- Published by Wiley in Congenital Anomalies
- Vol. 60 (6) , 166-174
Abstract
Background To date there is no law regulating the research use of human aborted fetuses in Japan. Objective The aim was to review the current status with historical background and legal/ethical problems limiting the research use of the tissues of aborted human fetuses. Method We reviewed literature via PubMed, Web of Science, Scopus, Japana Centra Revuo Medicina and CiNii, reports from various committees and research groups from Ministry of Health, Labour and Welfare (MHLW), and domestic books. Results Aborted human fetal tissues used for research purposes were first documented in the 1920s. The first guideline, the Peel Code was released in 1972. Since then, in Western countries, the research use of aborted fetuses has been less restricted compared with that of embryos, due to the following guidelines outlined by expert groups. Currently, aborted fetal tissues are commercially available for research purposes in the US. In Japan, only four indications are presented in “a public statement permitting research use of deceased fetuses' and ‘neonates' organs etc.” (1987). In the 2000s, expert committees of the MHLW concluded that research use of human aborted fetuses should be discontinued, and that comprehensive rules and independent regulations should be implemented. This issue has not been discussed in the Japanese legislature since 2003. Discussion Establishment of laws and guidelines for this issue is insufficient not only in Japan but also in other countries. It is important to secure transparency for making laws and guidelines and in obtaining public understanding.Keywords
This publication has 22 references indexed in Scilit:
- Human viruses: discovery and emergencePhilosophical Transactions of the Royal Society B: Biological Sciences, 2012
- Dopamine Cell Transplantation for Parkinson's Disease: The Importance of Controlled Clinical TrialsNeurotherapeutics, 2011
- Transplantation of Retinal Pigment Epithelial, Photoreceptor and other Cells as Treatment for Retinal DegenerationExperimental Eye Research, 1997
- Neural Transplantation as an Experimental Treatment Modality for Cerebral IschemiaNeuroscience & Biobehavioral Reviews, 1997
- In Utero Transplantation of Fetal Liver Stem Cells into Human FetusesJournal of Hematotherapy, 1996
- Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and researchJournal of Neurology, 1994
- Grafts of Fetal Dopamine Neurons Survive and Improve Motor Function in Parkinson's DiseaseScience, 1990
- Host-range mutants of adenovirus type 5 defective for growth in HeLa cellsVirology, 1977
- IMPLANTATION OF A FŒTAL THYMUS, RESTORING IMMUNOLOGICAL COMPETENCE IN A PATIENT WITH THYMIC APLASIA (DiGEORGE'S SYNDROME)The Lancet, 1968
- A Foetal Tissue BankBMJ, 1959